We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer (XCITE)

This study has been terminated.
(The study crossed the prospective futility boundary of primary endpoint)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01767857
First Posted: January 14, 2013
Last Update Posted: August 29, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
XBiotech, Inc.
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2017
  Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)